This country profile provides an overview of Madagascar’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
0%
Blinding trachoma
N/A
Intestinal worms
65%
Bilharzia
100%
River blindness
N/A
6.85 million people received treatment in Madagascar in 2017 13.37 million people did not receive treatment in Madagascar in 2017

Priorities for progress in Madagascar

  • Recognising that the plague outbreak severely hampered implementation of preventive chemotherapy for elephantiasis in 2017, Madagascar should work to restore and further improve coverage across the endemic NTDs in 2018.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage decreased from 44% in 2016 to 0% in 2017.

People needing treatment
19.64
People receiving treatment
0m

Blinding trachoma

Madagascar does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage decreased from 92% in 2016 to 65% in 2017.

Pre-sch and school-aged children needing treatment
6.64m
Pre-school and school-aged children receiving treatment
4.34m

Bilharzia

Treatment coverage increased from 43% in 2016 to 100% in 2017.

School-aged children needing treatment
4.4m
School-aged children receiving treatment
4.4m

River blindness

Madagascar does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Madagascar.